CN108142952A - A kind of complex peptides powder for improving fatigue, improving immunization - Google Patents
A kind of complex peptides powder for improving fatigue, improving immunization Download PDFInfo
- Publication number
- CN108142952A CN108142952A CN201711422939.7A CN201711422939A CN108142952A CN 108142952 A CN108142952 A CN 108142952A CN 201711422939 A CN201711422939 A CN 201711422939A CN 108142952 A CN108142952 A CN 108142952A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- oligopeptide
- complex peptides
- ginger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 92
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 82
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 33
- 230000003053 immunization Effects 0.000 title claims description 4
- 238000002649 immunization Methods 0.000 title claims description 4
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 66
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 66
- 241000209140 Triticum Species 0.000 claims abstract description 26
- 235000021307 Triticum Nutrition 0.000 claims abstract description 26
- 240000008042 Zea mays Species 0.000 claims abstract description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 25
- 241000251468 Actinopterygii Species 0.000 claims abstract description 24
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 24
- 239000005018 casein Substances 0.000 claims abstract description 24
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000021240 caseins Nutrition 0.000 claims abstract description 24
- 235000005822 corn Nutrition 0.000 claims abstract description 24
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 241000234314 Zingiber Species 0.000 claims description 22
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 22
- 235000008397 ginger Nutrition 0.000 claims description 22
- 206010016256 fatigue Diseases 0.000 claims description 13
- 108010011485 Aspartame Proteins 0.000 claims description 12
- 239000000605 aspartame Substances 0.000 claims description 12
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 12
- 235000010357 aspartame Nutrition 0.000 claims description 12
- 229960003438 aspartame Drugs 0.000 claims description 12
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 11
- 229960004853 betadex Drugs 0.000 claims description 11
- 229960004106 citric acid Drugs 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 150000005846 sugar alcohols Chemical class 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 2
- 208000033065 inborn errors of immunity Diseases 0.000 claims description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 claims description 2
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims 5
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims 5
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 10
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 235000010469 Glycine max Nutrition 0.000 description 17
- 230000006870 function Effects 0.000 description 14
- 239000000845 maltitol Substances 0.000 description 9
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 9
- 235000010449 maltitol Nutrition 0.000 description 9
- 229940035436 maltitol Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 238000000184 acid digestion Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- -1 hydroxyl isomaltulose Chemical compound 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a kind of complex peptides powders for having and improving fatigue, improving immunity, contain the raw materials such as ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphopeptide.Not only nutrition is balanced for complex peptides powder provided by the present invention, also has the function of that fatigue-relieving, raising are immune.
Description
Technical field
The invention belongs to food and food processing fields, and in particular to a kind of to have improvement fatigue, improve immunization
Complex peptides powder product and preparation method thereof.
Background technology
Biologically active peptide is derived from albumen, better than the multi-functional compounds of albumen, according to function come divide have immune-active peptides,
Neuroactive peptide, blood pressure lowering peptide and antibacterial polypeptide etc. are a variety of.Usually by -10 peptide of 2 peptide (2 peptides by 2 Amino acid profiles, n peptides by
N Amino acid profile) or relative molecular mass be known as oligopeptides or small peptide, such as glutathione less than the peptide of 2000D, they have more
Kind body metabolism and physiological regulation function, absorption easy to digest have immune promotion, hormone control, antibacterial, antiviral, blood pressure lowering, drop
The effects that blood fat, edible safety is high, is the work(of the most popular research topic of current international food circle and great development prospect
It can the factor.At the end of the 20th century, scientist is while the secret for cracking gene, also the another kind of marvellous object to being present in organism
Great interest occurs for Quality Research.This kind of substance is exactly biologically active peptide.
Modern nutriology research is found:The mankind ingest protein after gastral enzyme effect, are in the form of small peptide mostly
It digests and assimilates, the ratio very little absorbed in the form of free amino acid.Further experiment also disclosed peptide specific ionization amino acid
Digestion faster, absorb more, show the biological value of peptide and nutritive value specific ionization amino acid higher.This is also exactly that small molecule is lived
Property peptide infinite glamour where.Immunocompetence reduction, indigestion, metabolism can be caused different when lacking active peptide peptide in body
Often, the diseases such as dysplasia, patient are then difficult to rehabilitation.Scientist's suggestion, after the intake of human body basic nutrition is met, suitably
Supplement activity peptide nutrition is of great benefit to for health and rehabilitation.
This project is under guidance of traditional Chinese medicine theory, using a variety of small molecule bioactive peptides as primary raw material, to be equipped with a variety of
Auxiliary material, the product gone out using modern pharmaceutical process exploitation, functional stronger, market is broader.
Invention content
It is low etc. the purpose of the present invention is being directed to current people's fatiguability and body immunity, it provides a kind of from adjustment body
Gastrointestinal nutrition absorption is started with, and reaching fundamentally improves fatigue, the product for improving immunity.The present invention mainly uses following technology
Scheme：
A kind of complex peptides powder for improving fatigue, improving immunity, it includes following raw materials：Ocean fish oligopeptide powder,
Soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphopeptide, ginger.
This product formula has the characteristics that：
(1) this product raw material rich in essential amino acid and is arranged in pairs or groups equal by a variety of small molecule bioactive peptide perfect combinations
Weighing apparatus, can supplement the high-quality collagen of body.
(2) the bionic enzymatic technology of entirely autonomous intellectual property prepares small-molecular peptides, and safety easily absorbs and with unique
Nutrition and physiological function.
(3) ocean fish oligopeptide is with the following functions：
1. the high-quality collagen peptide of supplement, balance skin and muscle moisture, keep skin youth state；
2. preventing calcium loss, improve osteoporosis, delay bone joint degeneration；
3. it is transparent to improve cornea moistening, increase eyes transparency；
4. promoting muscle cell tight union, improve knot hoof tissue elasticity；
5. it adjusts endocrine, protection and strengthens viscera function；
6. increase immunity of organisms.
(4) soy peptide powder is with the following functions：
Anti-oxidant, blood pressure lowering reduces cholesterol, reducing blood lipid, the functions such as antifatigue, enhancing is immune.
1. rich in the necessary amino acid of a variety of human bodies, small molecule easily absorbs；
2. anti-hypertension reduces cholesterol, antithrombus formation, improve lipid-metabolism, prevent artery sclerosis, play blood and clean the street
Husband acts on；
3. enhancing human body physical agility and muscle strength, flesh red blood cell is promoted to restore, dispelling fatigue；
4. calcium, phosphorus and other absorption of trace elements, soybean peptide complexing calcium is promoted to be directly entered blood, it is not required to vitamin D ginseng
With；
4. promoting brain development, improving memory, prevent senile dementia；
5. enhancing phagocyte and the vigor of B cell, enhance immune function；
6. anticancer, anti-aging protect epidermal cell, prevent melanin pigmentation, eliminate oxyradical；
7. protecting liver, hepatic sclerosis is prevented, contributes to the recovery of liver function, and the generation of gall stone can be prevented；
8. couple diabetes patient has medical treatment and prevention effect.
(5) wheat oligopeptide is with the following functions：
1. cholesterol is inhibited to rise；
2. promoting insulin secretion, functional mass is oligomeric methionine, available for adjusting the blood glucose of people, improves diabetes
Symptom；
3. inhibiting the activity of angiotensin converting enzyme, blood pressure lowering, and normal arterial pressure is not reinstated；
4. rich in high glutamine, nervous function is effectively adjusted, can also make special dietary substance during intestinal dysfunction；
5. immunological regulation can stimulate body lymphopoiesis, enhance macrophage phagocytic function, improve body and resist
The ability of extraneous pathogenic infection reduces body incidence etc.；
6. antioxidant activity inhibits apoptosis, anti-aging.
(6) maize oligopeptide is with the following functions：
1. anti-oxidant, anti-aging；
2. anti-hypertension improves lipid-metabolism；
3. strengthen immunity reduces body incidence；
4. antifatigue, enhancing locomitivity；
5. protecting liver, experiment finds that corn peptide has sobering-up functions.
(7) casein phosphopeptide is with the following functions：
1. effectively facilitate absorption and utilization of the human body to calcium：Promote absorption of the small intestine to calcium, promote bone to the utilization of calcium,
Weaken osteoclast effect and inhibit the re-absorption of bone, improve senile osteoporosis, improve children's calcium deficiency；
2. improve mankind spermatozoon quality：Make the higher ability for penetrating egg cell of sperm, reduce sperm variation, send out embryo
It educates and more stablizes, treat sterility；
3. improving the bioavilability of the metal ions such as iron, zinc, magnesium, human body can be effectively facilitated to the divalent ore deposit such as calcium, iron, zinc
The absorption and utilization of object nutrient, are referred to as the peptide matters with metallic carrier.
The preferred weight proportion of the complex peptides powder is：30~120 parts of ocean fish oligopeptide powder, 30~120 parts of soy peptide powder,
30~120 parts of wheat oligopeptide, 30~120 parts of corn oligopeptide powder, 30~120 parts of casein phosphopeptide, ginger 30~120
Part.
The preferred weight proportion of the complex peptides powder is：120 parts of ocean fish oligopeptide powder, 100 parts of soy peptide powder, wheat are oligomeric
100 parts of peptide, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, 60 parts of ginger.
The preferred weight proportion of the complex peptides powder is：100 parts of ocean fish oligopeptide powder, 60 parts of soy peptide powder, wheat are oligomeric
60 parts of peptide, 60 parts of corn oligopeptide powder, 30 parts of casein phosphopeptide, 30 parts of ginger.
The preferred weight proportion of the complex peptides powder is：60 parts of ocean fish oligopeptide powder, 30 parts of soy peptide powder, wheat oligopeptide
30 parts, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, 60 parts of ginger.
The preferred weight proportion of the complex peptides powder is：30 parts of ocean fish oligopeptide powder, 120 parts of soy peptide powder, wheat are oligomeric
120 parts of peptide, 60 parts of corn oligopeptide powder, 120 parts of casein phosphopeptide, 30 parts of ginger.
To make complex peptides powder of the present invention that there is better mouthfeel, the auxiliary materials such as flavoring agent can be added in product, such as add in seasoning
One or more of agent maltitol, betadex, citric acid or Aspartame etc..The addition of various auxiliary materials is more preferable
Application the present invention product.
The complex peptides powder uses following preparation method：
By ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphopeptide, ginger and
Related flavoring agent such as one or more of maltitol, betadex, citric acid, Aspartame are uniformly mixed, packing,
To obtain the final product.
Improvement of the invention is tired, improves immune complex peptides powder has the function of that fatigue-relieving, raising are immunized.Suitable for easy
Tired crowd, the application of hypoimmunity crowd have the effects that treatment, prevention, health care.
Specific embodiment
The present invention is further described in detail, but be not limitation of the invention with reference to embodiment.
Embodiment 1
A kind of complex peptides powder for improving fatigue, improving immunity, supplementary material composition are：Ocean fish oligopeptide powder 120
Part, 100 parts of soy peptide powder, 100 parts of wheat oligopeptide, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, 60 parts of ginger,
30 parts of maltitol, 10 parts of betadex, 2 parts of citric acid, 0.5 part of Aspartame.(every part is 100g)
Preparation method is：By ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphorus
Sour peptide, ginger, maltitol, betadex, citric acid, Aspartame, be uniformly mixed, packing (5g/ bags) to get.
Embodiment 2
A kind of complex peptides powder for improving fatigue, improving immunity, supplementary material composition are：Ocean fish oligopeptide powder 100
Part, 60 parts of soy peptide powder, 60 parts of wheat oligopeptide, 60 parts of corn oligopeptide powder, 30 parts of casein phosphopeptide, 30 parts of ginger, wheat
60 parts of bud sugar alcohol, 2 parts of betadex, 8 parts of citric acid, 1 part of Aspartame.(every part is 500g)
Preparation method is：By ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphorus
Sour peptide, ginger, maltitol, betadex, citric acid, Aspartame, be uniformly mixed, packing (5g/ bags) to get.
Embodiment 3
A kind of complex peptides powder for improving fatigue, improving immunity, supplementary material composition are：Ocean fish oligopeptide powder 60
Part, 30 parts of soy peptide powder, 30 parts of wheat oligopeptide, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, 60 parts of ginger, wheat
30 parts of bud sugar alcohol, 5 parts of betadex, 5 parts of citric acid, 2 parts of Aspartame.(every part is 1kg)
Preparation method is：By ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphorus
Sour peptide, ginger, maltitol, betadex, citric acid, Aspartame, be uniformly mixed, packing (5g/ bags) to get.
Embodiment 4
A kind of complex peptides powder for improving fatigue, improving immunity, supplementary material composition are：Ocean fish oligopeptide powder 30
Part, 120 parts of soy peptide powder, 120 parts of wheat oligopeptide, 60 parts of corn oligopeptide powder, 120 parts of casein phosphopeptide, 30 parts of ginger,
120 parts of maltitol, 2 parts of betadex, 2 parts of citric acid, 0.5 part of Aspartame.(every part is 1kg)
Preparation method is：By ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphorus
Sour peptide, ginger, maltitol, betadex, citric acid, Aspartame, be uniformly mixed, packing (5g/ bags) to get.
Although reference be made herein to invention has been described for explanatory embodiment of the invention, but not limiting this hair
It is bright, it should be appreciated that those skilled in the art can be designed that a lot of other modifications and embodiment, these modifications and embodiment party
Formula will be fallen within spirit disclosed in the present application and spirit.For example, Sucralose be sweetener, can use Aspartame,
It is sucrose, xylitol, D-sorbite, mannitol, lactitol, maltitol, hydroxyl isomaltulose, erythrose alcohol, stevioside, sweet
Grass, Chinese grooseberry element, Siraitia grosvenorii element, one or more replacements in Talin, various sweeteners can arbitrary weight combination.More
Specifically, the application disclose in the scope of the claims, can be to the building block and/or layout of theme combination layout
Carry out a variety of variations and modifications.In addition to variations and improvements to the component parts and or layout, for people in the art
For member, function of the invention and effect also will be apparent.
Claims (8)
1. a kind of have the complex peptides powder for improving fatigue, improving immunization, it is characterised in that the complex peptides powder includes following
Raw material：Ocean fish oligopeptide powder, soy peptide powder, wheat oligopeptide, corn oligopeptide powder, casein phosphopeptide, ginger.
2. complex peptides powder as described in claim 1, it is characterised in that the weight proportion of the raw material is：Ocean fish oligopeptide powder
30~120 parts, 30~120 parts of soy peptide powder, 30~120 parts of wheat oligopeptide, 30~120 parts of corn oligopeptide powder, casein
30~120 parts of phosphoeptide, 30~120 parts of ginger.
3. complex peptides powder as claimed in claim 1 or 2, it is characterised in that the weight proportion of the raw material is：Marine fish is oligomeric
120 parts of Gly-His-Lys, 100 parts of soy peptide powder, 100 parts of wheat oligopeptide, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, life
60 parts of ginger.
4. complex peptides powder as claimed in claim 1 or 2, it is characterised in that the weight proportion of the raw material is：Marine fish is oligomeric
100 parts of Gly-His-Lys, 60 parts of soy peptide powder, 60 parts of wheat oligopeptide, 60 parts of corn oligopeptide powder, 30 parts of casein phosphopeptide, ginger
30 parts.
5. complex peptides powder as claimed in claim 1 or 2, it is characterised in that the weight proportion of the raw material is：Marine fish is oligomeric
60 parts of Gly-His-Lys, 30 parts of soy peptide powder, 30 parts of wheat oligopeptide, 30 parts of corn oligopeptide powder, 60 parts of casein phosphopeptide, ginger 60
Part.
6. complex peptides powder as claimed in claim 1 or 2, it is characterised in that the weight proportion of the raw material is：Marine fish is oligomeric
30 parts of Gly-His-Lys, 120 parts of soy peptide powder, 120 parts of wheat oligopeptide, 60 parts of corn oligopeptide powder, 120 parts of casein phosphopeptide, life
30 parts of ginger.
7. complex peptides powder as claimed in claim 1 or 2, it is characterised in that preparation method is：By ocean fish oligopeptide powder, greatly
Beans Gly-His-Lys, wheat oligopeptide, corn oligopeptide powder, casein phosphopeptide, ginger are uniformly mixed, add in other auxiliary materials such as malt
One or more of sugar alcohol, betadex, citric acid, Aspartame, be uniformly mixed, dispense to get.
8. the complex peptides powder described in claims 1 or 2 is being prepared for fatiguability crowd, the drug of hypoimmunity crowd, guarantor
Application in strong product and food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711422939.7A CN108142952A (en) | 2017-12-25 | 2017-12-25 | A kind of complex peptides powder for improving fatigue, improving immunization |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711422939.7A CN108142952A (en) | 2017-12-25 | 2017-12-25 | A kind of complex peptides powder for improving fatigue, improving immunization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108142952A true CN108142952A (en) | 2018-06-12 |
Family
ID=62462042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711422939.7A Pending CN108142952A (en) | 2017-12-25 | 2017-12-25 | A kind of complex peptides powder for improving fatigue, improving immunization |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108142952A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108967800A (en) * | 2018-08-13 | 2018-12-11 | 蔡艳霞 | A kind of functional solid beverage and preparation method thereof |
| CN109007844A (en) * | 2018-07-05 | 2018-12-18 | 王栋 | A kind of functional food |
| CN110604316A (en) * | 2019-10-30 | 2019-12-24 | 山东若尧特医食品有限公司 | Protein solid preparation and preparation method thereof |
| CN110720635A (en) * | 2019-11-18 | 2020-01-24 | 大连非得生物产业有限公司 | Tricholoma matsutake composite oligopeptide powder and preparation method thereof |
| CN110881666A (en) * | 2019-12-12 | 2020-03-17 | 西咸新区优恩生物科技股份有限公司 | Small molecule compound peptide preparation for special nutritional physique of astronaut |
| CN111603550A (en) * | 2020-06-29 | 2020-09-01 | 中食都庆（山东）生物技术有限公司 | Composition containing wheat oligopeptide and application thereof |
| CN111657489A (en) * | 2020-05-26 | 2020-09-15 | 颜如玉医药科技有限公司 | Composition containing protein peptide and preparation method thereof |
| CN111685330A (en) * | 2019-03-14 | 2020-09-22 | 云南白药天颐茶品有限公司 | Food formula capable of improving immunity |
| CN112841379A (en) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | Casein polypeptide gel candy and preparation method thereof |
| CN114831227A (en) * | 2022-03-29 | 2022-08-02 | 诺立(上海)生物工程有限公司 | Composite peptide nutrition health-care conditioner for conditioning feed intake and immune function of aquatic animals |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102823800A (en) * | 2012-09-28 | 2012-12-19 | 邹军 | Polypeptide nutritional health-care food containing marine fish oligopeptides |
| CN102885301A (en) * | 2012-09-19 | 2013-01-23 | 北京同仁堂健康药业股份有限公司 | Composition for enhancing immunity and preparation method thereof |
-
2017
- 2017-12-25 CN CN201711422939.7A patent/CN108142952A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885301A (en) * | 2012-09-19 | 2013-01-23 | 北京同仁堂健康药业股份有限公司 | Composition for enhancing immunity and preparation method thereof |
| CN102823800A (en) * | 2012-09-28 | 2012-12-19 | 邹军 | Polypeptide nutritional health-care food containing marine fish oligopeptides |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109007844A (en) * | 2018-07-05 | 2018-12-18 | 王栋 | A kind of functional food |
| CN108967800A (en) * | 2018-08-13 | 2018-12-11 | 蔡艳霞 | A kind of functional solid beverage and preparation method thereof |
| CN111685330A (en) * | 2019-03-14 | 2020-09-22 | 云南白药天颐茶品有限公司 | Food formula capable of improving immunity |
| CN110604316A (en) * | 2019-10-30 | 2019-12-24 | 山东若尧特医食品有限公司 | Protein solid preparation and preparation method thereof |
| CN110720635A (en) * | 2019-11-18 | 2020-01-24 | 大连非得生物产业有限公司 | Tricholoma matsutake composite oligopeptide powder and preparation method thereof |
| CN110881666A (en) * | 2019-12-12 | 2020-03-17 | 西咸新区优恩生物科技股份有限公司 | Small molecule compound peptide preparation for special nutritional physique of astronaut |
| CN111657489A (en) * | 2020-05-26 | 2020-09-15 | 颜如玉医药科技有限公司 | Composition containing protein peptide and preparation method thereof |
| CN111603550A (en) * | 2020-06-29 | 2020-09-01 | 中食都庆（山东）生物技术有限公司 | Composition containing wheat oligopeptide and application thereof |
| CN112841379A (en) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | Casein polypeptide gel candy and preparation method thereof |
| CN114831227A (en) * | 2022-03-29 | 2022-08-02 | 诺立(上海)生物工程有限公司 | Composite peptide nutrition health-care conditioner for conditioning feed intake and immune function of aquatic animals |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108142952A (en) | A kind of complex peptides powder for improving fatigue, improving immunization | |
| US7932288B2 (en) | Composition for relieving subjective symptoms of fatigue | |
| JPH09191852A (en) | Healthy food | |
| JP7108521B2 (en) | Composition for promoting an increase in the amount of BDNF in the body | |
| CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
| TW201635920A (en) | Muscle synthesis promoter | |
| CN104855975A (en) | Non-total-nutrient formula food for sarcopenia syndrome | |
| CN104855997A (en) | Non-whole nutrient formula food for osteoporosis | |
| JP2006273850A (en) | Suppression composition for lactic acid value elevation in blood, and food and drink comprising same | |
| JP5922863B2 (en) | Motor function improver | |
| WO2017026429A1 (en) | Muscle synthesis promoting agent | |
| US20200155589A1 (en) | Composition For Enchanced Recovery After Surgery (ERAS) | |
| WO2015137387A1 (en) | Muscle enhancing drug | |
| JP2011504464A (en) | Novel blood pressure lowering composition | |
| CN108771246B (en) | Composition for improving immunity and restoring physiological function of patients after operation or chemotherapy | |
| CN107998370B (en) | Composition capable of enhancing body motion ability and relieving motion fatigue | |
| JP2009107987A (en) | Muscle enhancer | |
| JP5394644B2 (en) | Muscle enhancer containing asperroside or its analog | |
| KR20200069621A (en) | Composition for enhancing exercise capacity comprising mealworm protein | |
| KR20160006941A (en) | composition for increasing of growth hormone secretory and quantity of motion during exercise | |
| CN114680339A (en) | Nutritional supplement for improving muscle attenuation and delaying senescence and application thereof | |
| JP4143387B2 (en) | healthy food | |
| CN101983721A (en) | Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement | |
| JP6225199B2 (en) | Motor function improver | |
| CN109645484A (en) | A kind of nutritional formulas for senile chronic disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180612 |
|
| WD01 | Invention patent application deemed withdrawn after publication |